Skip to content

Clinical trials

Nasopharyngeal Carcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nasopharyngeal Carcinoma Clear all

645 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20034
20042
20053
20066
20079
20089
20097
201012
201115
201215
201311
201417
201533
201631
201730
201838
201938
202047
202145
202265
202349
202460
202551
202638

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status233
Recruiting136
Completed130
Not yet recruiting55
Active, not recruiting51
Terminated28
Withdrawn7
Suspended3
No longer available1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University183
Fudan University26
Zhejiang Cancer Hospital21
Fujian Cancer Hospital18
Jiangxi Provincial Cancer Hospital14
National Cancer Institute (NCI)13
Ming-Yuan Chen10
Eye & ENT Hospital of Fudan University9
Nanfang Hospital, Southern Medical University9
National University Hospital, Singapore8

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nasopharyngeal Carcinoma645
Nasopharyngeal Neoplasms48
Recurrence27
Squamous Cell Carcinoma of Head and Neck27
Head and Neck Neoplasms25
Neoplasm Metastasis25
Epstein-Barr Virus Infections24
Carcinoma, Non-Small-Cell Lung13
Carcinoma, Renal Cell12
Laryngeal Neoplasms12

Trials

Showing 26 to 50 of 645. Each trial links to its page on Pharma Observatory.

545 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.